Results from the 2013 call for proposals to GLOBVAC
The GLOBVAC Programme Board had their meeting 18-19 March. The programme received a total of 61 applications by 4 September, 2013.
The call prioritized projects in the following thematic areas:
1. Prevention and treatment of, and diagnostics for, communicable diseases with particular relevance for low and lower-middle income countries;
2. Prevention and treatment of, and diagnostics for, neglected tropical diseases;
3. Family planning, reproductive, maternal, neonatal, child and youth health;
4. Health systems and health policy research;
5. Implementation research;
6. Innovation in technology and methods development for maternal and child health.
Please note: All applicants will receive a letter from the Research Council of Norway with details on the GLOBVAC Programme Board’s decision for funding. We kindly ask all applicants to refrain from contacting the Research Council until they have received the letters and assessments on “My RCN Web”.
Researcher projects/Young Scientist Grants approved for funding:
| Project no. | Title | Institution |
| 234364 |
Development of a heat-stable toxoid-based (ST) vaccine for enterotoxigenic Escherichia coli diarrhea |
University of Bergen |
| 234376 |
Harmonized Reproductive Health Registry Communication Strategies: Using Health Data to Empower Women and Health Systems |
Norwegian Institute of Public Health |
| 234424 |
Treatment of Chronic Lung Disease in HIV-infected Children in Africa. A multisite controlled trial of weekly azithromycin treatment. |
University of Tromsø |
| 234446 |
Novel vaccine designs for induction of broadly neutralizing antibodies against HIV |
University of Oslo |
| 234452 |
Can perineal tears and obstetric anal sphincter injuries in Palestine be prevented? A study of two different interventions. |
Oslo University Hospital HF |
| 234487 |
Malaria Chemoprevention for the post-discharge management of severe anaemia in children in Malawi, Uganda and Kenya: Moving towards policy |
University of Bergen |
| 234493 | Therapeutic vaccination and immune modulation - new treatment strategies for the multidrug-resistant tuberculosis pandemic |
Oslo University Hospital HF |
| 234505 |
Zinc as an adjunct for the treatment of very severe disease in infants younger than 2 months |
University of Bergen |
| 234506 |
Impact of Mycobacterium tuberculosis exosomes |
Oslo University Hospital HF |
| 234608 |
Strengthening International Collaboration for Capitalizing on Cost-Effective and Life-Saving Commodities (i4C) |
Norwegian Institute of Public Health |
Researcher projects approved for funding with reduced amount/contingent on satisfactory revision:
| Project no. | Title | Institution |
| 234431 | Novel Malaria Vaccines |
University of Oslo |
| 234457 | Improving diagnosis of extrapulmonary tuberculosis by implementation of a sensitive and specific assay in routine tuberculosis diagnostics |
University of Bergen |
| 234495 |
Impact of vitamin B12 on neurodevelopment and cognitive function from early life into school age. |
University of Bergen |
| 234497 |
NGOs and the transfer of global maternal health policies |
University of Oslo |
| 234502 | Food-grade bacterial vectors as novel tuberculosis vaccines |
Norwegian University of Life Sciences |
| 234514 |
Evaluation of the implementation, cost and long-term impact of performance based financing of health services in Tanzania |
Chr. Michelsen Institute |
The following applications for Young Scientist Grants will be contacted by the Research Council for certain clarifications before the final funding decision can be made:
| Project no. | Title | Institution |
| 234469 | Enfance Africaine - Mental child health in francophone Africa |
University of Bergen |
| 234500 | Acceptability and Effectiveness of Umbilical Cord Cleansing with 4% Chlorhexidine for the Prevention of Newborn Infections in Uganda |
University of Bergen |
Projects not listed above, did not receive funding in this call.
- Published:
- 19.03.2014
- Last updated:
- 13.09.2016
